German vaccine maker CureVac says interim data from late-stage testing of its coronavirus shot show a comparatively low effectiveness in protecting people against COVID-19
By Frank Jordans | AP, Washington Post: World
Wed, 06/16/2021 - 4:56am
German vaccine maker CureVac says interim data from late-stage testing of its coronavirus shot show a comparatively low effectiveness in protecting people against COVID-19